Crohn
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Health screening in Singapore: A more proactive approach to preventive care
Health screening in Singapore: A more proactive approach to preventive care Protocol combines comprehensive blood screening, doctor consultations and health coaching to help patients better understand their health risks and act earlier. At 17, Mr Mehdi Elaichouni was diagnosed with Crohn’s disease, a chronic inflammatory condition affecting the intestinal tract. While treatment helped manage acute flare-ups, he felt his care focused mainly on symptoms.
Genetically modified hookworms produce and deliver therapeutics
Genetically modified hookworms produce and deliver therapeutics Stephanie Baum Scientific Editor Robert Egan Associate Editor Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable coexistence with their hosts. Now, researchers at Washington University School of Medicine in St. Louis have harnessed that biological mechanism for...
Fluorescent nanosensor detects key gut biomarker in minutes for faster testing
Fluorescent nanosensor detects key gut biomarker in minutes for faster testing Sadie Harley Scientific Editor Robert Egan Associate Editor A research collaboration has developed a novel fluorescent nanosensor capable of rapidly detecting indole-3-propionic acid (IPA), an emerging biomarker linked to gut health and disease. The breakthrough is described in the team's paper, "Fluorescent Nanosensor for Indole-3-Propionic Acid Detection in Gut Health Monitoring," published in the journal...
Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update
Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug for ulcerative colitis. The medicine met its endpoints of demonstrating a clinically meaningful efficacy and a remission rate of about 40% for both doses tested, but also showed that there were cancer cases among patients taking the higher dose. "[The] cancer signal complicates matters," a Jefferies analyst said.